Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m

Canadian Association of Radiologists Journal

Volumn 48, Issue 3, 1997, Pages 199-202

  Murphy, Kieran J ^a   Line, Bruce R ^a   Malfetano, John ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

Bone; Etidronate; Methylene diphosphonate; Radionuclide scanning

Indexed keywords

ETIDRONIC ACID; MEDRONATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; AGED; BONE AND BONES; BONE DISEASES; BONE NEOPLASMS; DRUG INTERACTIONS; ETIDRONIC ACID; FEMALE; FEMUR; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RIBS; TECHNETIUM TC 99M MEDRONATE;

EID: 0030877097     PISSN: 00082902     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Krasnow A, Collier BD, Isitman AT, Hellman RS. False negative bone scan due to etidronate disodium therapy. Clin Nucl Med 1988;13:264-267.
2. Westmark K. Cyclical etidronate treatment of osteoporosis [letter]. N Engl J Med 1990;323(23):1634.
3. DeMeo J, Balseiro J, Cole TJ. Etidronate sodium therapy a cause of poor skeletal radiopharmaceutical uptake. Semin Nucl Med 1991;21(4):332-334.
4. Sandler ED, Parisi MT, Hattner RS. Duration of etidronate effect demonstrated by serial bone scintigraphy. J Nucl Med 1991; 32:1782-1784.
5. Hommeyer SH, Varney DM, Eary JF. Skeletal non-visualization in a bone scan secondary to intravenous etidronate therapy. J Nucl Med 1992;33:748-750.
6. Watt I, Hill P. Effects of acute administration of ethylene hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat. Br J Radiol 1981;1:592-596.